Becton, Dickinson & Co. (BDX)
147.12
+4.77
(+3.35%)
USD |
NYSE |
May 19, 16:00
147.12
0.00 (0.00%)
After-Hours: 16:24
Becton, Dickinson EPS Diluted (Quarterly) : -1.108 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.6165 |
| Baxter International, Inc. | -0.0291 |
| Intuitive Surgical, Inc. | 2.283 |
| Boston Scientific Corp. | 0.897 |
| Insulet Corp. | 1.298 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -37.00M |
| Revenue (Quarterly) | 4.714B |
| Total Expenses (Quarterly) | 4.751B |
| Enterprise Value | 55.48B |
| Gross Profit Margin (Quarterly) | 45.69% |
| Profit Margin (Quarterly) | -0.78% |
| Earnings Yield | 2.68% |
| Operating Earnings Yield | 7.76% |
| Normalized Earnings Yield | -1.247 |